Medical Equipment

Global Point-Of-Care Molecular Diagnostics Market Revenue and Share Analysis Through 2029

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the point-of-care molecular diagnostics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Point-Of-Care Molecular Diagnostics Market In The Period 2029-2034?

The point-of-care molecular diagnostics market has seen substantial growth in its size recently. It is projected to expand from $3.55 billion in 2024 to $3.98 billion in 2025, at a compound annual growth rate (CAGR) of 12.0%. The market’s historical growth can be attributed to an increasing requirement for quick disease diagnosis, a rise in infectious disease outbreaks, the expansion of telemedicine and remote testing, regulatory support for point-of-care diagnostics, and the need for personalized and precision medicine.

The point-of-care molecular diagnostics market size is projected to experience substantial expansion in the coming years, anticipated to reach $6.92 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.8%. This anticipated growth during the forecast period can be attributed to factors such as the miniaturization of diagnostic devices, the broader application of POC testing for cancer and genetic diseases, the development of customized molecular diagnostics for various uses, the incorporation of AI and machine learning for data analysis, and enhanced surveillance of emerging infectious diseases. Key trends expected within the forecast timeframe encompass lab-on-a-chip and microfluidic technologies, advancements in digital health and smartphone-based diagnostics, preparedness for point-of-care COVID-19 and future pandemics, AI-driven predictive diagnostics, and the rise of CRISPR-based molecular testing.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7046&type=smp

What Strategic Drivers Are Accelerating The Point-Of-Care Molecular Diagnostics Market Expansion?

The point-of-care molecular diagnostics market is anticipated to experience substantial growth, driven by the escalating incidence of infectious and respiratory ailments. These infections, often caused by microorganisms like viruses or bacteria affecting the respiratory system, transmit primarily through coughing, sneezing, or direct contact. Treatment for these conditions, particularly severe cases, encompasses various options such as inhalers, oral and intravenous medications, and increasingly, point-of-care molecular diagnostics for patient care. Illustratively, figures from the Office for National Statistics, a recognized UK national statistics institute, revealed that by the week ending December 9, 2022, in England, infection rates had risen among individuals aged 35 to 69 years and those within school years 12 to 24 years. Consequently, the widespread and rapid incidence of infectious and respiratory diseases, along with associated mortalities, is poised to propel the point-of-care molecular diagnostics market.

What Is The Detailed Segment Distribution Of The Point-Of-Care Molecular Diagnostics Market?

The point-of-care molecular diagnosticsmarket covered in this report is segmented –

1) By Product And Service: Assays And Kits, Instruments And Analyzers, Software And Services

2) By Technology: Reverse Transcription – Polymerase Chain Reaction (RT-PCR), In Situ Hybridization, Sequencing

3) By Application: Respiratory Diseases, Hospital Acquired Infections (HAIs), Cancer/Oncology, Hepatitis, Hematology

4) By End-User: Decentralized Labs, Hospitals, Home Care, Assisted Living Healthcare Facilities

Subsegments:

1) By Assays And Kits: Nucleic Acid Amplification Tests (NAATs), Rapid Diagnostic Tests, Molecular Detection Kits, Reagents And Consumables

2) By Instruments And Analyzers: PCR Machines, Microfluidic Devices, Sequencers, Point-of-Care Analyzers

3) By Software And Services: Data Management Software, Cloud-Based Solutions, Technical Support And Maintenance Services, Consultation And Training Services

How Are Global Trends Impacting The Development Of The Point-Of-Care Molecular Diagnostics Market?

Technological innovation is a major and growing trend in the point-of-care molecular diagnostics market. Key companies in the point-of-care molecular diagnostics market are striving to provide advanced technological solutions to strengthen their market position. These companies are adopting next-generation point-of-care molecular diagnostics technology solutions and related services, such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), mass spectrometry (MS), situ hybridizations, spectral karyotyping imaging, and DNA microarrays, among others, for implementation on POC devices to achieve faster analysis times and lower costs. For instance, in May 2023, Sensible Diagnostics, a US-based diagnostics company, unveiled a 10-minute point-of-care PCR system. Sensible Diagnostics is leveraging the experience Curative gained from its diagnostics business during the pandemic. The firm reported that it has performed over two million molecular point-of-care COVID-19 tests, and its PCR platform delivers results in 10-minutes.

Who Are The Major Stakeholders Operating In The Point-Of-Care Molecular Diagnostics Market?

Major companies operating in the point-of-care molecular diagnostics market include Abbott Laboratories, F Hoffmann-La Roche Ltd., BioMérieux SA, Danaher Corporation, Quidel Corporation, BioMerieux SA, Bio-Rad Laboratories Inc., Sysmex Corporation, Illumina Inc., Myriad Genetics Inc., Siemens Healthcare GmbH, Almac Group, Biogenex Laboratories Inc., Cepheid Inc., Epic Sciences Inc., Foundation Medicine Inc., Genomic Health Inc., Grail Inc., Hologic Inc., HTG Molecular Diagnostics Inc., Inivata Ltd., Invivoscribe Inc., MolecularMD Corporation, Natera Inc., NeoGenomics Laboratories Inc., Personal Genome Diagnostics Inc., Prometheus Laboratories Inc., Ventana Medical Systems Inc., Vermillion Inc., Guardant Health Inc., Exact Sciences Corporation, Biocartis Group NV, ArcherDx Inc., Bio-Techne Corporation, AccuBiotech Co. Ltd., Becton, Dickinson and Company, Chembio Diagnostics Inc., Credo Diagnostics Biomedical Pvt. Ltd., EKF Diagnostics, GenePOC Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/point-of-care-molecular-diagnostics-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Point-Of-Care Molecular Diagnostics Market?

North America was the largest region in the point-of-care molecular diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care molecular diagnostics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7046&type=smp

Browse Through More Reports Similar to the Global Point-Of-Care Molecular Diagnostics Market 2025, By The Business Research Company

Point Of Care Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-devices-and-equipment-global-market-report

Molecular Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795